How many acquisitions has AbbVie made so far?

AbbVie has completed 18 acquisitions so far, with an average acquisition amount of $7.94B.

Which countries does AbbVie usually acquire in?

AbbVie has made acquisitions in 4 countries with the most activity in United States and United Kingdom.

Which is AbbVie's latest acquisition?

AbbVie's most recent acquisition is Apogee Therapeutics, a Developer of therapeutics for immunological and inflammatory disorders, acquired in June 2026.

Which sectors does AbbVie target for acquisitions?

Most of AbbVie's acquisitions are in Immunotherapy (6) and Oncology (6).

In which year did AbbVie make the most acquisitions?

AbbVie was most active in 2024, with 4 acquisitions completed in that year.

List of 18 Acquisitions by AbbVie (Sep 2026)

AbbVie has made a total of 18 acquisitions. It acquired companies across 14 sectors, including Oncology, Immunotherapy, and Neurology, spanning 4 countries, led by United States, United Kingdom, and Switzerland. Peak acquisition years were 2024 and 2023 with 4 acquisitions each, and 2019 with 3. From 2020 to 2025, the average was 2.2 acquisitions per year, with 1 acquisition completed in the current calendar year. Its latest acquisition is Apogee Therapeutics, a Waltham-based developer of immunological and inflammatory disorder therapeutics founded in 2022, acquired in June 2026.

Here's the year on year acquisition history of AbbVie:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2025	1
2024	4
2023	4
2022	2
2019	3
2016	1
2015	1
2014	1

View all Acquisitions by AbbVie

Recent acquisitions by AbbVie

AbbVie's most recent acquisition - Apogee Therapeutics is a Developer of therapeutics for immunological and inflammatory disorders, founded in 2022 and located in Waltham. AbbVie acquired a 100% stake in it in June 2026 for a price of $*****.

Here is the list of all acquisitions by AbbVie sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jun 22, 2026	Apogee Therapeutics	nqxf	inhr	34	389
Jul 01, 2025	Capstan Therapeutics	qfzz	tjpq	13	305
Dec 13, 2024	Nimble Therapeutics	gcja	{yrp	94	782
Oct 28, 2024	Aliada Therapeutics	aipd	bvqf	69	969
Jun 27, 2024	Celsius Therapeutics	gubx	emdb	61	643